Ascendis Pharma A/S: how funds voted at the meeting of 27 May 2025
- Ticker
- ASND
- Meeting
- Season
- year to 30 June 2025
- Filers reporting
- 159
- Ballot items
- 7
159 filers on Form N-PX reported votes at the Ascendis Pharma A/S meeting of 27 May 2025. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Ascendis Pharma A/S has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2025. Filings read through . How the figures are made
The ballot
Item 1: Director elections
6 nominees. 97.2% of the reported votes are for. 12 filers withheld from or voted against at least one nominee.
1,478 vote records from 155 filers. 1 of the 152 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 41 fund families
- For 41
Item 2: Advisory vote on executive pay (say-on-pay)
2 vote records from 2 filers. 0 of the 2 filers that marked the item voted against management.
Item 3: Audit-related items (auditor ratification)
244 vote records from 154 filers. 1 of the 151 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 41 fund families
- For 41
Item 4: CAPITAL STRUCTURE: management items
The company's items in this category are shown together, because filers word and number them differently.
683 vote records from 151 filers. 1 of the 148 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 40 fund families
- For 40
Item 5: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
227 vote records from 144 filers. 79 of the 141 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 36 fund families
- For 14
- Against 22
- Against management 21
Item 6: CORPORATE GOVERNANCE: management items
The company's items in this category are shown together, because filers word and number them differently.
537 vote records from 156 filers. 1 of the 153 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 41 fund families
- For 41
Item 7: OTHER: management items
The company's items in this category are shown together, because filers word and number them differently.
43 vote records from 18 filers. 0 of the 18 filers that marked the item voted against management.
- Positions of 6 fund families
- For 6
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 3. Auditor |
|---|---|
| AllianceBernstein | For |
| Allspring | For |
| American Century | For |
| Artisan Partners | For |
| BlackRock and iShares | For |
| BNY Mellon | For |
| Brighthouse Funds | For |
| Capital Group and American Funds | For |
| Columbia Threadneedle | For |
| Equitable | For |
| Fidelity | For |
| Franklin Templeton | For |
| Goldman Sachs | For |
| Guggenheim and Rydex | For |
| Harbor Funds | For |
| Hartford Funds | For |
| Invesco | For |
| J.P. Morgan | For |
| Jackson National funds | For |
| Janus Henderson | For |
| John Hancock and Manulife | For |
| Lincoln Financial | For |
| Lord Abbett | For |
| MassMutual | For |
| MFS | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| Nationwide | For |
| Natixis and Loomis Sayles | For |
| Neuberger Berman | For |
| Northern Trust and FlexShares | For |
| Pacific Life funds | For |
| Principal | For |
| ProShares and ProFunds | For |
| Russell Investments | For |
| SEI | For |
| State Street and SPDR | For |
| T. Rowe Price | For |
| Transamerica | For |
| Vanguard | For |
| Victory Capital | For |
| Voya | For |
Questions
- How many filers reported votes at the Ascendis Pharma A/S meeting?
- 159 Form N-PX filers reported votes at the meeting of 27 May 2025. On say-on-pay, 0 of 2 filers that marked the item voted against management (0.0%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Ascendis Pharma A/S reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Ascendis Pharma A/S with a meeting date within three days of 27 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .